Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 389

1.

The induced decrease in TLR2 and TLR4 by cerebrolysin in the alcoholic liver of rats.

Mahmoudi J, Mahmoodpoor A, Amirnia M, Kazemi T, Chokhachi Baradaran P, Sheikh Najafi S, Sadigh-Eteghad S, Farajdokht F, Xu H, Belalzadeh M, Sandoghchian Shotorbani S.

J Cell Physiol. 2019 Feb 12. doi: 10.1002/jcp.28293. [Epub ahead of print]

PMID:
30756376
2.

[Cognitive control impairment in adult with attention deficit/hyperactivity disorder].

Chutko LS, Surushkina SY, Yakovenko EA, Anisimova TI, Antokhin EY, Kryukova EY.

Zh Nevrol Psikhiatr Im S S Korsakova. 2018;118(12):31-35. doi: 10.17116/jnevro201811812131. Russian.

PMID:
30698557
3.

Prospective, double blinded, comparative assessment of the pharmacological activity of Cerebrolysin and distinct peptide preparations for the treatment of embolic stroke.

Zhang L, Chopp M, Wang C, Zhang Y, Lu M, Zhang T, Zhang ZG.

J Neurol Sci. 2019 Jan 14;398:22-26. doi: 10.1016/j.jns.2019.01.017. [Epub ahead of print]

4.

Effects of cerebrolysin on functional outcome of patients with traumatic brain injury: a systematic review and meta-analysis.

Ghaffarpasand F, Torabi S, Rasti A, Niakan MH, Aghabaklou S, Pakzad F, Beheshtian MS, Tabrizi R.

Neuropsychiatr Dis Treat. 2018 Dec 27;15:127-135. doi: 10.2147/NDT.S186865. eCollection 2019.

5.

Cerebrolysin increases motor recovery and decreases inflammation in a mouse model of autoimmune encephalitis.

Toader LE, Roşu GC, Cătălin B, Pirici I, Gîlceavă IC, Albu VC, Istrate-Ofiţeru AM, Mureşanu DF, Pirici D.

Rom J Morphol Embryol. 2018;59(3):755-762.

6.

[Prevention of progression of cognitive decline in the first-degree relatives of patients with Alzheimer's disease].

Selezneva ND, Roshchina IF, Korovaitseva GI, Gavrilova SI.

Zh Nevrol Psikhiatr Im S S Korsakova. 2018;118(10):30-36. doi: 10.17116/jnevro201811810130. Russian.

PMID:
30499493
7.

Cerebrolysin Reduces Astrogliosis and Axonal Injury and Enhances Neurogenesis in Rats After Closed Head Injury.

Zhang Y, Chopp M, Zhang ZG, Zhang Y, Zhang L, Lu M, Zhang T, Winter S, Doppler E, Brandstäetter H, Mahmood A, Xiong Y.

Neurorehabil Neural Repair. 2018 Nov 30:1545968318809916. doi: 10.1177/1545968318809916. [Epub ahead of print]

PMID:
30499355
8.

Patient and Physician Perspectives in a Case of Severe Traumatic Brain Injury.

Casis RM.

Neurol Ther. 2018 Dec;7(2):171-178. doi: 10.1007/s40120-018-0117-9. Epub 2018 Nov 10.

9.

Cerebrolysin for the Treatment of Aneurysmal Subarachnoid Hemorrhage in Adults: A Retrospective Chart Review.

Park YK, Yi HJ, Choi KS, Lee YJ, Kim DW, Kwon SM.

Adv Ther. 2018 Dec;35(12):2224-2235. doi: 10.1007/s12325-018-0832-8. Epub 2018 Nov 9.

PMID:
30414051
10.

Prevention of memory impairment induced by post-traumatic stress disorder by cerebrolysin.

Alzoubi KH, Al-Ibbini AM, Nuseir KQ.

Psychiatry Res. 2018 Dec;270:430-437. doi: 10.1016/j.psychres.2018.10.008. Epub 2018 Oct 6.

PMID:
30316170
11.

[Comorbid cognitive impairments in children with nocturnal enuresis and their treatment].

Chutko LS, Surushkina SY, Yakovenko EA, Anisimova TI, Volov MB, Rozhkova AV, Sergeev AV.

Zh Nevrol Psikhiatr Im S S Korsakova. 2018;118(5. Vyp. 2):57-63. doi: 10.17116/jnevro20181185257. Russian.

PMID:
30141789
12.

Intranasal cerebrolysin improves cognitive function and structural synaptic plasticity in photothrombotic mouse model of medial prefrontal cortex ischemia.

Sadigh-Eteghad S, Geranmayeh MH, Majdi A, Salehpour F, Mahmoudi J, Farhoudi M.

Neuropeptides. 2018 Oct;71:61-69. doi: 10.1016/j.npep.2018.07.002. Epub 2018 Jul 10.

PMID:
30054019
13.

Cerebrolysin: a multi-target drug for recovery after stroke.

Brainin M.

Expert Rev Neurother. 2018 Aug;18(8):681-687. doi: 10.1080/14737175.2018.1500459. Epub 2018 Jul 18.

PMID:
30004268
14.

[Anti-inflammatory effects of neurotrophic therapy (a pilot study)].

Malashenkova IK, Krynskiy SA, Hailov NA, Ogurtsov DP, Selezneva ND, Fedorova YB, Ponomareva EV, Kolyhalov IV, Gavrilova SI, Didkovsky NA.

Zh Nevrol Psikhiatr Im S S Korsakova. 2018;118(5):39-44. doi: 10.17116/jnevro20181185139. Russian.

PMID:
29927402
15.

Cerebrolysin attenuates hyperalgesia, photophobia, and neuroinflammation in a nitroglycerin-induced migraine model in rats.

Mahmoudi J, Mohaddes G, Erfani M, Sadigh-Eteghad S, Karimi P, Rajabi M, Reyhani-Rad S, Farajdokht F.

Brain Res Bull. 2018 Jun;140:197-204. doi: 10.1016/j.brainresbull.2018.05.008. Epub 2018 May 9.

PMID:
29752991
16.

Cerebrolysin and Aquaporin 4 Inhibition Improve Pathological and Motor Recovery after Ischemic Stroke.

Catalin B, Rogoveanu OC, Pirici I, Balseanu TA, Stan A, Tudorica V, Balea M, Mindrila I, Albu CV, Mohamed G, Pirici D, Muresanu DF.

CNS Neurol Disord Drug Targets. 2018;17(4):299-308. doi: 10.2174/1871527317666180425124340.

PMID:
29692268
17.

Effectiveness of arginase inhibitors against experimentally induced stroke.

Barakat W, Fahmy A, Askar M, El-Kannishy S.

Naunyn Schmiedebergs Arch Pharmacol. 2018 Jun;391(6):603-612. doi: 10.1007/s00210-018-1489-1. Epub 2018 Mar 29.

PMID:
29600431
18.

[The efficacy of prevention of postoperative cognitive dysfunction in cardiac surgeries with the use of the cerebrolysin].

Polushin AY, Yanishevskiy SN, Maslevtsov DV, Krivov VO, Beskrovnaya OV, Molchan NS.

Zh Nevrol Psikhiatr Im S S Korsakova. 2017;117(12):37-45. doi: 10.17116/jnevro201711712137-45. Russian.

PMID:
29376982
20.

Prospective, randomized, blinded, and placebo-controlled study of Cerebrolysin dose-response effects on long-term functional outcomes in a rat model of mild traumatic brain injury.

Zhang Y, Chopp M, Gang Zhang Z, Zhang Y, Zhang L, Lu M, Zhang T, Winter S, Brandstätter H, Mahmood A, Xiong Y.

J Neurosurg. 2018 Nov 1;129(5):1295-1304. doi: 10.3171/2017.6.JNS171007.

PMID:
29303438

Supplemental Content

Loading ...
Support Center